Precipio (PRPO) Net Income towards Common Stockholders (2010 - 2025)
Precipio (PRPO) reported Net Income towards Common Stockholders of $526000.0 for Q4 2025, up 244.11% on a YoY basis from $152858.3 in Q4 2024, and up 765.82% quarter-over-quarter from -$79000.0 in Q3 2025.
Precipio (PRPO) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends
Precipio has reported Net Income towards Common Stockholders for 16 years, with the latest figure at $526000.0 in Q4 2025.
- For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 244.11% year-over-year to $526000.0; the trailing twelve-month figure through Dec 2025 stood at -$363000.0 (up 91.54% YoY), and the FY2025 full-year result was -$363000.0, up 91.54% from the prior year.
- Net Income towards Common Stockholders for Q4 2025 stood at $526000.0, up from -$79000.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $925000.0 in Q4 2023, with the low at -$4.6 million in Q1 2022.
- Historically, Net Income towards Common Stockholders has averaged -$1.6 million across 5 years, with a median of -$1.7 million in 2021.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders tumbled 216.12% — and 2025, when it surged 244.11%.
- Precipio's Net Income towards Common Stockholders stood at -$2.2 million in 2021, then decreased by 3.85% to -$2.3 million in 2022, then soared by 140.39% to $925000.0 in 2023, then tumbled by 139.46% to -$365000.0 in 2024, then surged by 244.11% to $526000.0 in 2025.
- The last three Net Income towards Common Stockholders figures came in at $526000.0 (Q4 2025), -$79000.0 (Q3 2025), and $74000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 141.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Precipio | 36.92 Mn | 34.27 Mn | 3.13 Mn | 526,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 526,000.00 |
| Sep 30, 2025 | -79,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | -884,000.00 |
| Dec 31, 2024 | -365,000.00 |
| Sep 30, 2024 | -626,000.00 |
| Jun 30, 2024 | -1.22 Mn |
| Mar 31, 2024 | -2.08 Mn |
| Dec 31, 2023 | 925,000.00 |
| Sep 30, 2023 | -1.46 Mn |
| Jun 30, 2023 | -2.29 Mn |
| Mar 31, 2023 | -3.03 Mn |
| Dec 31, 2022 | -2.29 Mn |
| Sep 30, 2022 | -3.18 Mn |
| Jun 30, 2022 | -2.14 Mn |
| Mar 31, 2022 | -4.59 Mn |
| Dec 31, 2021 | -2.21 Mn |
| Sep 30, 2021 | -1.86 Mn |
| Jun 30, 2021 | -3.01 Mn |
| Mar 31, 2021 | -1.45 Mn |